Yongqi Mu

YongQi Mu currently serves as Vice President of Development Chemistry at Eyconis, Inc. since March 2024 and has held various leadership roles at Ascendis Pharma, including Senior Director & Head of Development Chemistry. Prior experience includes positions at Relypsa, where YongQi Mu progressed from Associate Director of Discovery Chemistry to Technical Operations, Strategy and Development. Additional roles include Senior Scientist at Nektar Therapeutics and Principal Scientist at Relypsa. YongQi Mu began a career in research at Theravance as a Research Scientist. Educational credentials include a Ph.D. in Medicinal Chemistry from Wayne State University, a postdoctoral degree from Stanford University, and a BS in Chemistry from Beijing Normal University.